文献速递腹部CTDSA

血管造影CT与多排CT对胰岛素瘤检出和定位的比较

Comparison of angio-CT versus multidetector CT in the detection and location for insulinomas.
PubMed 文献 · Clin Radiol · 2020-07-09

回顾性纳入2015年4月至2018年4月临床疑似胰岛素瘤并接受MDCT和血管造影CT的连续患者,以手术和病理为参考标准比较两种方法的检出敏感度和定位准确率。血管造影CT的检出敏感度94.4%、定位准确率90.7%,均显著高于MDCT的68.5%和58.3%(p<0.05),动脉期血管造影CT的Az值0.93高于MDCT的0.84。

要点

  • 血管造影CT检出敏感度94.4%、定位准确率90.7%,显著高于MDCT的68.5%和58.3%(p<0.05)。
  • 动脉期肿瘤-胰腺对比血管造影CT为285±48.7 HU,MDCT为105.1±25 HU,差异有统计学意义(p<0.05)。
  • 动脉期Az值血管造影CT 0.93、MDCT 0.84;门静脉期分别为0.62和0.54。

核心结论

  • 血管造影CT的肿瘤显示度更高,对胰岛素瘤的检出和定位优于MDCT。

研究设计与样本

  • 回顾性研究,2015年4月至2018年4月连续纳入60例临床疑似胰岛素瘤并接受MDCT和血管造影CT检查的患者。
  • 最终分析54例胰岛素瘤患者,平均年龄53.8岁(范围21-69岁)。
  • 以手术和病理结果为参考标准,由两名放射科医师定量测量动脉期和门静脉期肿瘤、正常胰腺实质的CT衰减值及肿瘤-胰腺对比,并评估观察者间一致性。
  • 采用卡方检验比较两种方法的检出敏感度和定位准确率,并以受试者工作特征(ROC)分析比较诊断效能。

关键影像表现/征象

  • 动脉期肿瘤-胰腺对比:MDCT为105.1±25 HU,血管造影CT为285±48.7 HU,两者差异有统计学意义(p<0.05)。

诊断标准与关键数值

  • 检出敏感度:MDCT 68.5%,血管造影CT 94.4%,血管造影CT显著高于MDCT(p<0.05)。
  • 定位准确率:MDCT 58.3%,血管造影CT 90.7%,血管造影CT显著高于MDCT(p<0.05)。
  • Az值:动脉期血管造影CT 0.93、MDCT 0.84;门静脉期血管造影CT 0.62、MDCT 0.54。
  • 动脉期血管造影CT对胰岛素瘤检出的准确性显著更高(p<0.05)。

临床应用与阅片要点

  • 原文结论认为血管造影CT的肿瘤显示度更高,对胰岛素瘤的检出和定位优于MDCT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To compare the diagnostic performance of angio-computed tomography (CT) with multidetector CT (MDCT) in the detection and location for insulinomas.

MATERIALS AND METHODS: From April 2015 to April 2018, 60 consecutive patients who underwent MDCT and angio-CT for clinically suspected insulinomas were identified retrospectively. The CT attenuation values of tumours, normal pancreatic parenchyma, and tumour-to-pancreas contrast were measured quantitatively in the arterial phase (AP) and portal venous phase (PVP) of both methods by two radiologists with interobserver agreement. The detection sensitivity and localisation accuracy were calculated based on surgical and pathological findings, which are the reference standard, and compared between both methods using the chi-square test. Receiver operating characteristic (ROC) analysis was performed to compare diagnostic performance.

RESULTS: Fifty-four patients with insulinoma with a mean age of 53.8 years old (range 21-69 years) were reviewed. The detection sensitivity and location accuracy were 68.5%, 58.3% for MDCT and 94.4%, 90.7% for angio-CT, respectively; the detection sensitivity and location accuracy of angio-CT were significantly higher than those obtained with MDCT (p < 0.05). The mean tumour-to-pancreas attenuations were 105.1±25 HU in the AP of MDCT and 285±48.7 HU in the AP of angio-CT. There were significant differences in the tumour-to-pancreas contrast in the AP between MDCT and angio-CT (p < 0.05). The Az values were 0.93 and 0.84 for the AP of angio-CT and MDCT, 0.62 and 0.54 for the PVP. The AP of angio-CT was significantly more accurate for insulinoma detection (p < 0.05).

CONCLUSION: Angio-CT produces higher tumour conspicuity and is superior in the detection and location of insulinomas compared to MDCT.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Fu J, Zhang J, Wang Y, et al. Comparison of angio-CT versus multidetector CT in the detection and location for insulinomas. Clin Radiol. 2020. PMID: 32654756. doi:10.1016/j.crad.2020.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。